The Global Health Screening Market is expected to grow with a CAGR of 5.1% in the forecast period of 2021 to 2028. The years considered for the study are as mentioned below:

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-health-screening-market

The global health screening market is a wide market, including a specific number of key players and many local players. The market has witnessed increased strategic developments owing to favorable market scenarios.   

The major players dealing in the global health screening market are introducing products of different strengths, launching new products, approval by different agencies, and adopting strategic initiatives such as acquisition, agreement, business expansion, award, and recognition into the market. This helped companies to maximize sales with an enhanced product portfolio.

For instance,

• In September 2021, Quest Diagnostic Corporation announced that it had reached 57 million COVID-19 molecular diagnostic and serology testing for COVID-19. This shows the testing capacity of the company that will lead to a rise in revenue in the forecast period

Quest Diagnostic Incorporated is the dominating player in the global health screening market. The other key players existing in the market are GRAIL, Eurofins Scientific, Exact Sciences Corporation, SYNLAB International GmbH, UNILABS, LabPLUS, BioReference Laboratories, Sonic Healthcare Limited, ACM Global Laboratories, Cerba Healthcare, Quidel Corporation, Innova Medical Group, Amedes Holding GmbH, RadNet, Inc., Natera, Inc., Trinity Biotech, Nuffield Health, RepeatDx, NeoGenomics Laboratories, H.U Group Holdings, Inc., Lifelabs, ARUP Laboratories, Q2 Solutions, Genova Diagnostics, Life Length, DNA Labs India, Healius Limited, Telomere Diagnostics, Charles River, Ambry Genetics, SpectraCell Laboratories, Inc., Dr. Lal PathLabs, and Laboratory Corporation of America, among others.

QUEST DIAGNOSTIC INCORPORATED

Quest Diagnostic Incorporated headquarters in New Jersey, U.S. and was founded in 1990. It has public ownership. The company is focused on providing world-class clinical testing and management services. Diagnostic Information Services and Diagnostic Solutions are the business segments for the company in which Diagnostic Information Services is the market-focused business segment. The company has wide product categories such as Solutions for Physicians and Hospitals, medical conditions, Specialty, in which all these are also the market-focused categories. The company is attaining lucrative growth through several strategic initiatives.

For instance,

• In August 2021, Quest Diagnostic Corporation announced a partnership with eMed to offer guided COVID-19 Rapid Antigen Testing to aid employees in a safer workplace. This will increase the company’s response toward COVID-19 and will increase the social presence of the company along with its revenue

The company has a wide presence across Europe, the Middle East, and Africa, Asia-Pacific, Americas. The company has subsidiaries such as Quest Diagnostics Subsidiary Holdings Ltd. (UK), Quest Diagnostics do Brasil Ltda. (Brazil), Quest Diagnostics Ireland Limited (Ireland), Quest Diagnostics (Shanghai) Co., Ltd. (China), Quest HealthConnect, LLC (U.S.), among others.

SONIC HEALTHCARE LIMITED

Sonic Healthcare Limited is headquartered in Sydney, Australia and was founded in 1981. The company focuses on providing healthcare providers with specialist operations in pathology and laboratory medicine, radiology, general practice medicine and corporate medical services. Laboratory, Imaging, and others are the business segment among which laboratory is the market focused business segment. Laboratory medicine / pathology, Diagnostic imaging / radiology and Primary care medical services are the product services given by the company in which Laboratory medicine / pathology is the market focused product category

For Instance:

• In March, Sonic healthcare announced that they have acquired Pathologie Hamburg- a pathology practice laboratory. This acquisition has provided the company with increased production and testing capabilities.

The company is present in Europe, North America And Asia-Pacific.

Pathology Laboratories, Inc. (United States), American Esoteric Laboratories, Inc. (United States), Clinical Pathology Laboratories Southeast, Inc. (United States), Medvet BV (Belgium), A.M.L. BV (Belgium) among others are the major subsidiaries of the company

LABORATORY CORPORATION OF AMERICA

The company was found in 1995, and it has headquarters in Texas, U.S. It has public ownership. The company focuses on delivering answers to all the health problems and deliver the testing in hospitals and medical research or to the patients. The company has product and service categories such as Abdominal Fluid Cytology, Abdominal Bleeding Profile, Abnormal PT, ABO Grouping, among others which are also the market-focused categories. The company is attaining lucrative growth through several strategic initiatives.  

For instance,

• In September 2021, Laboratory Corporation of America acquired the Myriad Autoimmune’s Vectra testing business. This will increase the service portfolio of the company and will increase the revenue generated by the company in the forecast period

The company has a wide presence across Asia-Pacific, North America, Europe. The company has subsidiaries such as Accupath Diagnostic Laboratories, Inc. Alpha Medical Laboratory LLC Beacon LBS IPA, Inc. Beacon Laboratory Benefit Solutions, Inc. CannAmm GP Inc. CannAmm Limited Partnership.